Nvidia CEO Jensen Huang recently highlighted AI's transformative potential, stating it democratizes programming by enabling ...

Mr. Trump had been eager to celebrate his success at NATO and revel in the fact that he had conducted an attack that none of ...

Revolution Medicines projected its cash and equivalents of $2.1 billion would last into the second half of 2027. With new ...

Mr. Trump had been eager to celebrate his success at NATO and revel in the fact that he had conducted an attack that none of ...

Enrollment in company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for ...

IEEE Spatial Web chair George Percivall explains how the recently-approved IEEE P2874 Spatial Web Standard complements ...

However, despite these challenges, progress is rapid. Karpathy suggested that we are entering the era of "Software 3.0." ...

Sanofi to advance Kymera’s next-generation oral IRAK4 degrader development candidate, KT-485, into clinical testing and will not advance KT-474 In preclinical testing, KT-485 demonstrated increased ...

Joby reports $127M Q1 2025 EBITDA loss but remains funded with $813M. Despite no commercial revenues, it trades at a ~$7B ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...